Skip to main content

Advertisement

Log in

Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Previous evidence supports a role for growth hormone (GH)–insulin-like growth factor (IGF)-I deficiency in the pathophysiology of osteopenia/osteoporosis in adult thalassemia. Moreover, serum IGF-II has never been studied in this clinical condition. Thus, we elected to study the GH secretory status and the levels of circulating somatomedins, correlating these parameters with bone mineral density (BMD) and biochemical markers of bone turnover. A hundred and thirty-nine normal weight adult thalassemic patients (72 men and 67 women) were studied. Lumbar and femoral neck BMD were measured in 106/139 patients. Sixty-eight patients underwent growth hormone releasing hormone plus arginine testing. Measurement of baseline IGF-I and IGF-II was performed in all patients, while osteocalcin, C-terminal telopeptide of type I collagen (CTx), and urinary cross-linked N-telopeptides of type I collagen (NTx) were assayed in 95 of them. Femoral and lumbar osteoporosis/Z score below the expected range for age were documented in 61.3 and in 56.6 % of patients, respectively. Severe GH deficiency (GHD) was demonstrated in 27.9 % of cases, whereas IGF-I SDS was low in 86.3 %. No thalassemic patients displayed circulating levels of IGF-II below the reference range. GH peaks were positively correlated with femoral, but not lumbar, Z score. No correlations were found between GH peaks and osteocalcin, CTx and NTx. GH peaks were positively correlated with IGF-I values, which in their turn displayed a positive correlation with osteocalcin, CTx, and NTx. No correlations emerged between IGF-I values and either femoral or lumbar Z scores. No correlations were found between IGF-II and any of the following parameters: GH peaks, osteocalcin, CTx, NTx, femoral Z score, and lumbar Z score. Our study, besides providing for the first time evidence of a normal IGF-II production in thalassemia, contributes to a better understanding of the involvement of the somatotropin-somatomedin axis in the pathophysiology of bone demineralization in this disease. In particular, the contribution of GHD to femoral osteoporosis appears to be likely mediated by locally produced rather than circulating IGF-I.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. M. Scacchi, L. Danesi, A. Cattaneo, E. Valassi, F. Pecori Giraldi, C. Argento, E. D’Angelo, N. Mirra, V. Carnelli, L. Zanaboni, B. Tampieri, M.D. Cappellini, F. Cavagnini, Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites. Clin. Endocrinol. (Oxf.) 69, 202–207 (2008)

    Article  CAS  Google Scholar 

  2. S. Perrotta, M.D. Cappellini, F. Bertoldo, V. Servedio, G. Iolascon, L. D’Agruma, P. Gasparini, M.C. Siciliani, A. Iolascon, Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. Br. J. Haematol. 111, 461–466 (2000)

    Article  CAS  PubMed  Google Scholar 

  3. D. Tiosano, Z. Hochberg, Endocrine complications of thalassemia. J. Endocrinol. Investig. 24, 716–723 (2001)

    Article  CAS  Google Scholar 

  4. E. Voskaridou, E. Terpos, New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br. J. Haematol. 127, 127–139 (2004)

    Article  CAS  PubMed  Google Scholar 

  5. L. Pratelli, E. Verri, M. Fortini, S. Marconi, C. Zolezzi, P.M. Fornasari, M.R. Gamberini, V. De Sanctis, Chelation therapy and bone metabolism markers in thalassemia major. J. Pediatr. Endocrinol. Metab. 19, 1335–1342 (2006)

    Article  CAS  PubMed  Google Scholar 

  6. E. Canalis, Insulin like growth factors and the local regulation of bone formation. Bone 14, 273–276 (1993)

    Article  CAS  PubMed  Google Scholar 

  7. S. Sittadjody, R. Ilangovan, T. Thangasamy, R.C. Vignesh, S. Veni, A.G. Bertoni, S. Srinivasan, C. Subramanian, N. Srinivasan, Age-related changes in serum levels of insulin-like growth factor-II and its binding proteins correlate with calcaneal bone mineral density among post-menopausal South-Indian women. Clin. Chim. Acta 414, 281–288 (2012)

    Article  CAS  PubMed  Google Scholar 

  8. G. Brabant, A. von zur Muhlen, C. Wuster, M.B. Ranke, J. Kratzsch, W. Kiess, J.M. Ketelslegers, L. Wilhelmsen, L. Hulthén, B. Saller, A. Mattsson, J. Wilde, R. Schemer, P. Kann, Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm. Res. 60, 53–60 (2003)

    Article  CAS  PubMed  Google Scholar 

  9. P. Garnero, O. Borel, P.D. Delmas, Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis. Clin. Chem. 47, 694–702 (2001)

    CAS  PubMed  Google Scholar 

  10. E. Ghigo, G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, F. Camanni, New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 134, 352–356 (1996)

    Article  CAS  PubMed  Google Scholar 

  11. M. Scacchi, L. Danesi, A. Cattaneo, E. Valassi, F. Pecori Giraldi, C. Argento, E. D’Angelo, N. Mirra, V. Carnelli, L. Zanaboni, M.D. Cappellini, F. Cavagnini, Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin. Endocrinol. (Oxf.) 67, 790–795 (2007)

    Article  CAS  Google Scholar 

  12. V. De Sanctis, N. Skordis, M.C. Galati, G. Raiola, M. Giovannini, G. Candini, K. Kaffe, I. Savvides, S. Christou, Growth hormone and adrenal response to intramuscular glucagon test and its relationship to IGF-1 production and left ventricular ejection fraction in adult B-thalassemia major patients. Pediatr. Endocrinol. Rev. 8(Suppl 2), 290–294 (2011)

    PubMed  Google Scholar 

  13. A.I. Pincelli, N. Masera, L. Tavecchia, M. Perotti, S. Perra, R. Mariani, A. Piperno, G. Mancia, G. Grassi, G. Masera, GH deficiency in adult B-thalassemia major patients and its relationship with IGF-1 production. Pediatr. Endocrinol. Rev. 8(2), 284–289 (2011)

    PubMed  Google Scholar 

  14. D. Bansal, S. Venkateshwaran, N. Khandelwal, R.K. Marwaha, Quantitative computed tomography is unreliable for measurement of bone mineral density in inadequately chelated adolescent patients with beta-thalassemia major: a case-control study. Pediatr. Blood Cancer 56, 409–412 (2011)

    Article  PubMed  Google Scholar 

  15. L.S. Topor, P. Melvin, C. Giancaterino, C.M. Gordon, Factors associated with low bone density in patients referred for assessment of bone health. Int. J. Pediatr. Endocrinol. 2013, 4 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  16. A. Soltani, B. Larijani, P. Khashayar, M. Rezaei Hemami, S. Fakhari, The relationship between anthropometric parameters and bone mineral density in an Iranian referral population. Acta Med. Iran 52, 505–510 (2014)

    PubMed  Google Scholar 

  17. F. Rossi, S. Perrotta, G. Bellini, L. Luongo, C. Tortora, D. Siniscalco, M. Francese, M. Torella, B. Nobili, V. Di Marzo, S. Maione, Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels. Haematologica 99, 1876–1884 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  18. P. Wong, P.J. Fuller, M.T. Gillespie, V. Kartsogiannis, P.G. Kerr, J.C. Doery, E. Paul, D.K. Bowden, B.J. Strauss, F. Milat, Thalassemia bone disease: a 19-year longitudinal analysis. J. Bone Miner. Res. 29, 2468–2473 (2014)

    Article  CAS  PubMed  Google Scholar 

  19. G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)

    Article  CAS  PubMed  Google Scholar 

  20. A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. J. Zapf, E. Schoenle, E.R. Froesch, Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur. J. Biochem. 87, 285–296 (1978)

    Article  CAS  PubMed  Google Scholar 

  22. J.R. Florini, K.A. Magri, D.Z. Ewton, P.L. James, K. Grindstaff, P.S. Rotwein, “Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266, 15917–15923 (1991)

    CAS  PubMed  Google Scholar 

  23. C.E. Stewart, P.L. James, M.E. Fant, P. Rotwein, Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. J. Cell Physiol. 169, 23–32 (1996)

    Article  CAS  PubMed  Google Scholar 

  24. K.W. Siddals, M. Westwood, J.M. Gibson, A. White, IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte. J. Endocrinol. 174, 289–297 (2002)

    Article  CAS  PubMed  Google Scholar 

  25. M. Ishibe, T. Ishibashi, K. Kaneda, T. Koda, R.N. Rosier, J.E. Puzas, Stimulation of bone formation in vivo by insulin-like growth factor-II in rats. Calcif. Tissue Int. 63, 36–38 (1998)

    Article  CAS  PubMed  Google Scholar 

  26. C.A. Conover, E.W. Johnstone, R.T. Turner, G.L. Evans, F.J. John Ballard, P.M. Doran, S. Khosla, Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm. IGF Res. 12, 178–183 (2002)

    Article  CAS  PubMed  Google Scholar 

  27. J.G. Kim, C.S. Shin, Y.M. Choi, S.Y. Moon, S.Y. Kim, J.Y. Lee, The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin. Endocrinol. (Oxf.) 51, 301–307 (1999)

    Article  CAS  Google Scholar 

  28. S. Ormarsdottir, O. Ljunggren, H. Mallmin, H. Olofsson, W.F. Blum, L. Loof, Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density. Liver 21, 123–128 (2001)

    Article  CAS  PubMed  Google Scholar 

  29. S. Amin, B.L. Riggs, E.J. Atkinson, A.L. Oberg, L.J. Melton 3rd, S. Khosla, A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J. Bone Miner. Res. 19, 1075–1083 (2004)

    Article  CAS  PubMed  Google Scholar 

  30. B.L. Riggs, L.J. Melton, R.A. Robb, J.J. Camp, E.J. Atkinson, L. McDaniel, S. Amin, P.A. Rouleau, S. Khosla, A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J. Bone Miner. Res. 23, 205–214 (2008)

    Article  PubMed  Google Scholar 

  31. S. Boonen, S. Mohan, J. Dequeker, J. Aerssens, D. Vanderschueren, G. Verbeke, P. Broos, R. Bouillon, D.J. Baylink, Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J. Bone Miner. Res. 14, 2150–2158 (1999)

    Article  CAS  PubMed  Google Scholar 

  32. P. Gillberg, H. Olofsson, H. Mallmin, W.F. Blum, S. Ljunghall, A.G. Nilsson, Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif. Tissue Int. 70, 22–29 (2002)

    Article  CAS  PubMed  Google Scholar 

  33. R.D. Murray, J.E. Adams, S.M. Shalet, A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. J. Clin. Endocrinol. Metab. 91, 432–438 (2006)

    Article  CAS  PubMed  Google Scholar 

  34. T. Seck, B. Scheppach, S. Scharla, I. Diel, W.F. Blum, H. Bismar, G. Schmid, B. Krempien, R. Ziegler, J. Pfeilschifter, Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J. Clin. Endocrinol. Metab. 83, 2331–2337 (1998)

    CAS  PubMed  Google Scholar 

Download references

Funding

This study was funded in part by the Italian Ministry of Health (Grant Number RF-2009-1519507).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Scacchi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

This paper is dedicated to the memory of Professor Francesco Minuto.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scacchi, M., Danesi, L., Cattaneo, A. et al. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins. Endocrine 53, 551–557 (2016). https://doi.org/10.1007/s12020-016-0865-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-0865-1

Keywords

Navigation